A patient presented for outpatient diabetes education stating, “I really don’t know why I am here. I know I need to lose weight. I don’t know what else you can tell me.” She was reassured when I told her that there are people who are a perfect weight, exercise regularly, …
Read More »Measuring CKD and Cognitive Impairment in Type 2 African Americans
Participants with CKD had significantly poorer processing speed and working memory…. Both type 2 diabetes and chronic kidney disease (CKD) have been associated with structural brain changes. In previous studies, people with type 2 diabetes have been shown to have reduced total gray matter and WM volume, as well as …
Read More »Type 2 Diabetes Remission Very Rare in Non-Bariatric Surgery Patients
American researchers looked at data on over 120,000 type 2 patients to find out what rates of remission were…. Previous studies have shown that bariatric surgery can result in long-term weight loss, improvement in cardiovascular risk factors, and a reduction in mortality rate of 15% from baseline. However, in a …
Read More »Obesity and CHD Association in Type 2 Diabetes Patients
Are obesity and CHD truly associated?… Researchers from the U.S. and China examined data on 30,434 diabetic patients from the Louisiana State University Hospital-Based Longitudinal Study (10,955 men and 19,479 women). Patients included were 30-95 years of age without a history of CHD or stroke in the Louisiana State University …
Read More »Genetic Variations Associated with Traits Underlying Type 2 Diabetes in Mexican-Americans
But narrowing down the exact genes responsible proves to be complicated… While people of Mexican ancestry are nearly twice as likely to develop type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin. In an effort to understand …
Read More »Glargine vs. Liraglutide in Poorly Controlled Type 2 Diabetes Treatment
Both medications lowered HbA1c and both groups of patients lost weight…. This randomized, multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5–12%. Subjects were assigned to 24 weeks of insulin glargine, titrated to target fasting plasma glucose of 4.0–5.5 mmol/L or liraglutide, escalated …
Read More »Linagliptin/Metformin Combination vs Linagliptin Monotherapy for Type 2 Diabetes
Earlier treatment for poorly controlled type 2 diabetes patients is advocated… Researchers from the University of Calgary, Alberta, Canada, evaluated glucose-lowering treatment strategies with linagliptin and metformin in people with newly diagnosed type 2 diabetes and marked hyperglycemia, a prevalent population for which few dedicated studies of oral antidiabetes drugs …
Read More »Lower Mood and its Association with Risk Factors of Type 2 Diabetes
Low mood in healthy children is associated with poorer metabolic health independently of adiposity… Mood comprises two main traits – positive and negative affect, both associated with depression and anxiety. Studies in children have linked depression with obesity, but the association with metabolic health is unclear. Researchers from Plymouth University …
Read More »Anemia and Much Older Type 2 Diabetes Patients
Anemia is higher in older type 2 diabetes patients… The chances of an anemia diagnosis increase with age and it affects roughly about 10% of those 65 years of age or older. In diabetes patients, the probability of diagnosing anemia could be two to threefold higher and furthermore, from previous …
Read More »New Enzyme Inhibitor May Prevent Onset of Type 2 Diabetes
The new drug apparently works by stabilizing metabolites of an omega-3 fatty acid called DHA… Researchers Bruce Hammock at the University of California, Davis, and Joan Claria at the University of Barcelona found that an enzyme called soluble epoxide hydrolase, or sEH, inhibitor both prevented the onset of diabetes and …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.